Anastazia M. Older Aguilar

current as KIR 2 DL 3 Adaptable NK Cell Receptor Than KIR 2 DL 1 Is a More Refined but Less the Binding Site for HLA-C Shows That Mutation at Positively Selected Positions in Fleischhauer and

P. Parham, P. Norman, L. Abi-Rached, 2012 .

Class I That Recognizes the C1 Epitope of MHC Lacking an Activating NK Cell Receptor Humans Differ from Other Hominids in

L. Abi-Rached, L. Guethlein, Achim K. Moesta, 2010 .

Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers

Rosanna Lagos, M. Levine, K. Subbarao, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Regulators of Human NK Cells with HLA-C To Become the Major Variable Coevolution of Killer Cell Ig-Like Receptors

L. Abi-Rached, L. Guethlein, Achim K. Moesta, 2010 .

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview

C. MacLennan, A. Steele, Anastazia M. Older Aguilar, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MHC-C KIR Associated with the Emergence of Haplotype Reveals Expansion of Lineage III KIR ) Genes : Definition of an Orangutan KIR Evolution of Killer Cell Ig-Like Receptor (

P. Parham, Anastazia M. Older Aguilar, L. Guethlein, 2007 .

Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.

Diane J Post, P. Roberts, J. Bresee, 2019, Vaccine.

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays

I. Feavers, C. MacLennan, S. Rijpkema, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.